Selected Talks

American Society of Nephrology (ASN) Renal Week
Philadelphia, PA, November, 2008
Click here to retrieve your archive of CME certificates obtained via HDCN


TBA 		Therapeutic Issues in Crescentic Glomerulonephritis and Vasculitis
Luis F. Flores-Suarez, MD, PhD, Marten Segelmark, MD, and Ulrich Specks, MD


TBA 		Renal Neoplasms: What the Nephrologist Should Know
Stephen M. Bonsib, MD and Gary R. Hudes, MD


TBA 		New Insights into Antibody-Mediated Rejection
Elaine F. Reed, PhD, and Mark D. Pescovitz, MD


TBA 		Personalized Therapy for Kidney Disease
Brad H. Rovin, MD, Dany Anglicheau, MD, PhD, and Melanie S. Joy, PharmD


1.5 		Collagen Nephropathies
Billy G. Hudson, PhD, and Clifford E. Kashtan, MD


1.5 		Phosphorus: Bystander or Cause of Pathology?
Daniel W. Coyne, MD, and William F. Finn, MD


1.5 		Membranous Glomerulopathy
Giuseppe Remuzzi, MD, and Jack F. Wetzels, MD, PhD


1.5 		Boots on the Ground: Do We Have Enough Personnel to Fight the Battle Against CKD?
Jay B. Wish, MD and Beth M, Piraino, MD


1.5 		Controversies in Vascular Access
Arif Asif, MD and Aris Q. Urbanes, MD


1.5 		Nephrology Quiz and Questionnaire: Fluids and Electrolyte and Glomerular Disorders
Biff Palmer, MD, and Charles D. Pusey, DSc


1.5 		Primary Care in Nephrology: Preoperative Risk Assessment and Management of Glycemic Control
Thomas A. Golper, MD, and John P. Mordes, MD


1.5 		IgA Nephropathy: Time to Change Our Approach?
John Feehally, MD, and Ronald J. Hogg, MD


1.5 		The Sexual Life Cycle of Women with CKD
Lynne P. Yao, MD, Susan H. Hou, MD, and Manjula Kurella-Tamura, MD


1.5 		Resistant Hypertension: A Challenge for the Nephrologist
Vito M. Campese, MD and Susan P. Steigerwalt, MD


1.5 		New Frontiers in Phosphorus Homeostasis in CKD
L. Darryl Quarles, MD, and Myles S. Wolf, MD (Hartmut H. Malluche, MD, moderator)


1.5 		Managing CKD-MBD through the Disease Continuum
Ravi I. Thadhani, MD, and Bryan R. Kestenbaum, MD (Hartmut H. Malluche, MD, moderator)


1.0 		Care of the Chronic Kidney Disease Patient
Ruth C. Campbell, MD, and Jeffrey S. Berns, MD. (Andrew Z. Fenves, MD, FASN, moderator, and Daniel C. Batlle, MD, discussant)


1.5 		Restoring Balance: New Therapeutic Approaches to Acute Decompensated Heart Failure
Lee R. Goldberg, MD, Robert W. Schrier, MD, and Mihai Gheorghiade, MD.


1.5 		The Year in Nephrology: Hypertension and Metabolic Renal Syndrome
Karen A. Griffin, MD, FASN, and Srinivasan Beddhu, MD.


1.0 		Nephrology Roundtable: Glucose Transport and Targets for Intervention
Dick De Zeeuw, MD, PhD, and Ernest M. Wright, PhD (Moderators: Ricardo Correa-Rotter, MD and Mark J. Sarnak, MD, FASN).


1.5 		Shades of Grey: Key Questions in the Future of Treatment for CKD-Related Anemia
Robert D. Toto, MD; Rebecca J. Schmidt, DO, FASN.


1.5 		The ESA Controversy: The Role of Intravenous Iron
Tomaz Ganz, MD,PhD; Rajiv Agarwal, MD, MBBS, FASN; Anatole Besarab, MD, FACP. (Moderator: Adeera Levin, MD)
Please look also at related talks from
2007 ASN Renal Week Talks
2006 ASN Renal Week Talks
2005 ASN Renal Week Talks
2004 ASN Renal Week Talks
2003 ASN Renal Week Talks
2002 ASN Renal Week Talks
2001 ASN Renal Week Talks
2000 ASN Renal Week Talks
1999 ASN Renal Week Talks
1998 ASN Renal Week Talks

  
Identify recent discoveries in basic, translational, and clinical research in nephrology.
Construct new research questions in nephrology based on updated scientific and clinical advances in nephrology-related disciplines.
Translate recent advances in the areas of general nephrology, dialysis, transplantation, and hypertension into new standards and approaches to clinical care of patients with kidney diseases and related disorders.

See Individual Lecture Pages

Each talk, or group of talks, depending on length, is accredited for the appropriate number of AMA PRA Category 1 Credits™. Sometimes talks are organized into groups of two or more and paired with a single CME post-test, which must be completed along with an evaluation form.
Date of Web Release: See individual talks
Credit Eligible Through: April 30, 2010
Credits/Completion Time: See individual talks
Target Audiences: Physicians, researchers, trainees.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
ACCREDITATION AND DESIGNATION STATEMENTS:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credit Designation Statement: The American Society of Nephrology designates this educational activity AMA PRA Category 1 Credits™. Physicians should only claim credit commensurat with the extent of their participation in the activity.
SPONSORSHIP / SUPPORT :
All lectures selected were from Renal Week 2008, and all were put together under supervision of the ASN Scientific Program Committee. Web posting of lectures in the free zone was supported by grants to the ASN from pharmaceutical companies. See each symposium page for details of industry sponsorship and support.
FACULTY DISCLOSURE STATEMENTS :
In accordance with the disclosure policies of the Accreditation Council for Continuing Medical Education (ACCME) and FDA guidelines, it is a policy at the ASN for individuals who are in a position to control the content of an educational activity to disclose to the activity participants: 1) the existence of all relevant financial relationships with any commercial interests or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/materials, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; for this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.

Based on the disclosures provided, the ASN is responsible for identifying and resolving all conflicts of interest prior to presenting the educational activity to the learner. The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

Faculty disclosures are posted on each individual talk page.
DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Faculty disclosure about individual talks is posted on each individual talk page.
DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player (downloadable from www.microsoft.com) the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from www.adobe.com) is required to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send an email to or email@asn-online.org, or call HDCN at 630-325-3276, Monday through Friday from 10 AM - 4 PM Central Standard Time.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.